Evidence map›Paper›PMID 37622721›Full record

SynthesisJournal of global health2023

A systematic review for the impacts of global approaches to regulating electronic nicotine products.

Duo Yan, Zicheng Wang, Linnea Laestadius, Kavita Mosalpuria, Fernando A Wilson, Alice Yan, Xiaoyang Lv, Xiaotian Zhang, Soumitra S Bhuyan, Yang Wang

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Journal of global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Cost Comparison and Spending on Tobacco Products: Evidence From A Nationally Representative Sample of Adult E-cigarette Users.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Duo YanSchool of Public Health, Peking University, Beijing, China.
Zicheng WangChina Center for Health Development Studies, Peking University, Beijing, China.
Linnea LaestadiusJoseph J. Zilber College of Public Health, University of Wisconsin - Milwaukee, Milwaukee, Wisconsin USA.
Kavita MosalpuriaMatheson Center for Health Care Studies, University of Utah, Salt Lake City, Utah, USA.
Fernando A WilsonMatheson Center for Health Care Studies, University of Utah, Salt Lake City, Utah, USA.
Alice YanDepartment of Research Patient Care Service, Stanford Health Care, Palo Alto, California, USA.
Xiaoyang LvSchool of Public Health, Peking University, Beijing, China.
Xiaotian ZhangChina Center for Health Development Studies, Peking University, Beijing, China.
Soumitra S BhuyanEdward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, New Jersey, USA.
Yang WangChina Center for Health Development Studies, Peking University, Beijing, China.
Peking University · CNUniversity of Utah · USPrinceton Public Schools · USStanford Health Care · USUniversity of Wisconsin–Milwaukee · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The rapid increase in electronic nicotine product (ENP) use among young people has been a global public health challenge, given the potential harm of ENPs and nicotine dependence. Many countries have recently introduced legislations to regulate ENPs, but the impacts of these policies are poorly understood. This systematic review aims to critically synthesise empirical studies on the effects of global regulations regarding ENPs on the prevalence of use, health outcomes and their determinants, using the 4A marketing mix framework (acceptability, affordability, accessibility and awareness). Methods: Following the PRISMA guideline, we searched PubMed, Embase, Scopus, Web of Science, Academic Search Complete, Business Source Complete, and APA PsycINFO databases from inception until June 14, 2022 and performed citation searches on the included studies. Reviewed literature was restricted to peer-reviewed, English-language articles. We included all pre-post and quasi-experimental studies that evaluated the impacts of e-cigarette policies on the prevalence of ENP use and other health outcomes. A modified Joanna Briggs Institute (JBI) Critical Appraisal checklist for quasi-experimental studies was used for quality assessment. Due to heterogeneity of the included studies, we conducted a narrative synthesis of evidence. Results: Of 3991 unduplicated records screened, 48 (1.2%) met the inclusion criteria, most were from high-income countries in North America and Europe and 26 studies measured self-reported ENPs use. Flavour restrictions significantly decreased youth ENP use and taxation reduced adult use; mixed results were found for the impacts of age restrictions. Indoor vaping restrictions and the European Tobacco Products Directive (TPD) did not seem to reduce ENP use based on existing studies. Changes in determinants such as sales and perceptions corroborated our conclusions. Few studies assessed the impacts of other regulations such as advertising restrictions and retail licensing requirements. Conclusions: Flavour restrictions and taxes have the strongest evidence to support effective control of ENPs, while others need powerful enforcement and meaningful penalties to ensure their effectiveness. Future research should focus on under-examined policies and differential impacts across sociodemographic characteristics and countries. Registration: PROSPERO CRD42022337361.

Indexed as

Electronic Nicotine Delivery SystemsNicotineAdolescentAdultCommerceDatabases, FactualElectronicsHumansNicotine

Identifiers

PMID37622721
PMCPMC10451104
OpenAlexW4386154082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.